查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
人工器官市场规模、份额和成长分析（按器官类型、固定方法、材料、最终用户和地区划分）—产业预测（2026-2033 年）
市场调查报告书
商品编码
1896091

人工器官市场规模、份额和成长分析（按器官类型、固定方法、材料、最终用户和地区划分）—产业预测（2026-2033 年）

Artificial Organs Market Size, Share, and Growth Analysis, By Organ Type (Artificial kidney, Artificial liver), By Fixation (Implantable, Wearable), By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 182 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球人工器官市场预计到 2024 年将达到 307.5 亿美元，到 2025 年将达到 331.8 亿美元，到 2033 年将达到 609.6 亿美元，预测期（2026-2033 年）的复合年增长率为 7.9%。

全球人工器官市场正经历显着成长，其主要驱动力是人口老化以及65岁以上人口对器官移植需求的不断增长。该年龄层尤其容易出现移植后併发症，这进一步增加了对先进人工器官设备的需求。随着病患需求的增加，移植等待名单不断扩大，各方正积极进行创新工作，以提高器官移植体系的效率和课责。此外，3D生物列印技术的进步至关重要，它能够製造出排斥风险极低的人工器官。同时，人工智慧的融合正在革新製造工艺，并实现个人化的器官和供体评估，从而帮助患者做出关于移植方案的决策流程。这一蓬勃发展的局面凸显了医疗产业中一个快速成长的领域。

全球人工器官市场驱动因素

肾衰竭、心臟病和肝功能障碍等慢性疾病的日益增多是推动人工器官市场发展的主要因素。随着越来越多的人面临与器官相关的健康挑战，对透析机、人工心臟和肝臟支持系统等人工解决方案的需求持续成长。人口老化和人们对提高生活品质日益增长的关注进一步加剧了这一趋势，凸显了创新救生干预措施的紧迫性。随着越来越多的患者寻求有效的解决方案来控制病情，人工器官市场预计将显着增长，因为它满足了全球一项重要的医疗需求。

全球人工器官市场面临的限制因素

儘管人工器官领域取得了显着的技术进步，但义肢及相关医疗程序的高昂成本仍是市场扩张的一大障碍。这些设备的研发和製造成本高昂，使得世界上有很大一部分人口，特别是发展中地区的人口，难以负担。因此，这种经济障碍限制了低收入或医疗服务匮乏的患者获得和广泛使用义肢解决方案，最终阻碍了潜在的市场成长和发展机会。

全球人工器官市场趋势

全球人工器官市场正呈现出一个显着的趋势，即3D列印技术在假体器官製造上的应用。这项技术进步使得为每位患者客製化器官成为可能，从而提高了复杂器官系统的精确性、功能性和生物相容性。透过简化製造流程，3D列印显着降低了成本和研发週期，使先进的假体器官能够惠及更广泛的患者群体。因此，这种创新方法正在推动市场显着成长，吸引投资和研究，致力于开发更先进的应用，以期改善依赖人工器官系统患者的生活品质。

目录

介绍

  • 调查目标
  • 定义
  • 市场覆盖范围

调查方法

  • 资讯收集
  • 二手和一手资料资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 前景
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场动态
    • 司机
    • 机会
    • 抑制因素
    • 任务
  • 波特分析

关键市场考察

  • 技术分析
  • 价值链分析
  • 市场生态系统
  • 专利分析
  • 监管环境
  • 创新矩阵
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

按器官类型分類的人工器官市场

  • 人工肾臟
  • 人工肺
  • 人工心臟
  • 人工肝臟
  • 其他的

以固定方法分類的人工器官市场

  • 嵌入式
  • 穿戴式装置

按材料分類的人工器官市场

  • 硅酮
  • 聚氨酯
  • 其他的

按最终用户分類的人工器官市场

  • 医院
  • 学术研究机构
  • 专科诊所

按地区分類的人工器官市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲（MEA）
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争格局

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市占率（2025 年）

主要企业简介

  • Edwards Lifesciences Corporation
  • Cochlear Limited
  • Zimmer Biomet Holding Inc.
  • Jarvik Heart, Inc.
  • Boston Scientific Corporation
  • Berlin Heart GmbH
  • SynCardia Systems LLC
  • CARMAT
  • BiVACOR Inc.
  • AWAK Technologies
  • Wearable Artificial Organs, Inc.
  • Medtronic Plc
  • ALung Technologies, Inc.
  • Fresenius Medical Care
  • Johnson & Johnson
  • TransMedics, Inc
  • Abott
简介目录
Product Code: SQMIG35H2303

Global Artificial Organs Market size was valued at USD 30.75 Billion in 2024 and is poised to grow from USD 33.18 Billion in 2025 to USD 60.96 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global market for artificial organs is witnessing significant growth driven by the rising elderly population and increased demand for organ transplants among individuals aged 65 and older. This demographic is particularly vulnerable to post-implantation complications, heightening the need for advanced prosthetic devices. As transplant waiting lists expand due to escalating patient needs, innovative initiatives aim to enhance system efficacy and accountability within organ transplant frameworks. Additionally, advancements in 3D bioprinting technology are pivotal, allowing for the creation of artificial organs that minimize rejection risks. Furthermore, the integration of artificial intelligence is set to transform manufacturing technologies, enabling tailored organ and donor assessments that facilitate patient decision-making processes regarding transplantation options. This progressive landscape highlights a burgeoning sector within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Organs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Organs Market Segments Analysis

Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Organs Market

The growing prevalence of chronic diseases, including kidney failure, heart disease, and liver dysfunction, significantly propels the artificial organs market. As more individuals face organ-related health challenges, the demand for prosthetic solutions-such as dialysis machines, artificial hearts, and liver support systems-continues to escalate. This trend is intensified by an aging population and a heightened focus on improving quality of life, which collectively underscore the urgent need for innovative life-saving interventions. As more patients seek effective solutions to manage their conditions, the market for artificial organs is poised for substantial growth, addressing critical healthcare needs globally.

Restraints in the Global Artificial Organs Market

Although there have been significant technological advancements in the field of artificial organs, the considerable expense associated with prosthetics and their associated medical procedures continues to hinder market expansion. The substantial costs involved in the research, development, and manufacturing of these devices render them inaccessible for a large portion of the global population, particularly in developing regions. As a result, this financial barrier restricts the availability and adoption of prosthetic solutions among patients with limited income or insufficient access to healthcare services, ultimately impeding potential market growth and development opportunities.

Market Trends of the Global Artificial Organs Market

The global artificial organs market is witnessing a significant trend driven by the integration of 3D printing technology in prosthetics. This advancement facilitates the production of customized, patient-specific organs, enhancing accuracy, functionality, and biocompatibility of complex organ systems. By streamlining manufacturing processes, 3D printing significantly reduces costs and development times, making advanced prosthetics more accessible and appealing to a broader patient demographic. As a result, this innovative approach is fostering substantial growth within the market, attracting investments and research into more sophisticated applications that promise to enhance the quality of life for individuals relying on artificial organ systems.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Patent Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Artificial Organs Market by Organ Type

  • Market Overview
  • Artificial Kidney
  • Artificial Lung
  • Artificial Heart
  • Artificial Lever
  • Others

Artificial Organs Market by Fixation

  • Market Overview
  • Implantable
  • Wearable

Artificial Organs Market by Material

  • Market Overview
  • Silicon
  • Polyurethane
  • Others

Artificial Organs Market by End User

  • Market Overview
  • Hospitals
  • Academic and Research Institutes
  • Specialty Clinics

Artificial Organs Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cochlear Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holding Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jarvik Heart, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Berlin Heart GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SynCardia Systems LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARMAT
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BiVACOR Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AWAK Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wearable Artificial Organs, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ALung Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TransMedics, Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments